Phase III Preclinical Trials in Translational Stroke Research: Community Response on Framework and Guidelines

Translational Stroke Research

Volumn 7, Issue 4, 2016, Pages 241-247

  Boltze, Johannes ^a,b   Wagner, Daniel Christoph ^b   Henninger, Nils ^c   Plesnila, Nikolaus ^d   Ayata, Cenk ^e  

^a UNIVERSITY OF LÜBECK   (Germany)

^b FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Animal models; Experimental; Focal ischemia; Multicenter preclinical trials; Randomized controlled trials; Regeneration and recovery

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; FINANCIAL MANAGEMENT; METHODOLOGY; MULTICENTER STUDY; NONHUMAN; PRACTICE GUIDELINE; PRECLINICAL STUDY; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; TRANSLATIONAL RESEARCH; CLINICAL TRIAL; DEMOGRAPHY; ECONOMICS; HUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); PROCEDURES; QUESTIONNAIRE; STANDARDS; STROKE; TRENDS;

CLINICAL TRIALS, PHASE III AS TOPIC; GUIDELINES AS TOPIC; HUMANS; RESEARCH DESIGN; RESIDENCE CHARACTERISTICS; STROKE; SURVEYS AND QUESTIONNAIRES; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84974777138     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-016-0474-6     Document Type: Article

References (9)

1. Dirnagl U, Hakim A, Macleod M, Fisher M, Howells D, Alan SM, et al. A concerted appeal for international cooperation in preclinical stroke research. Stroke. 2013;44(6):1754–60.
2. Dirnagl U, Fisher M. International, multicenter randomized preclinical trials in translational stroke research: it’s time to act. J Cereb Blood Flow Metab. 2012;32(6):933–5.
3. Llovera G, Hofmann K, Roth S, Salas-Pérdomo A, Ferrer-Ferrer M, Perego C, et al. Results of a preclinical randomized controlled multicenter trial (pRCT): anti-CD49d treatment for acute brain ischemia. Sci Transl Med. 2015;7(299):299ra121.
4. Boltze J, Ayata C,Wagner DC, Plesnila N. Preclinical phase III trials in translational stroke research: call for collective design of framework and guidelines. Stroke. 2014;45(2):357.
5. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009;40(6):2244–50.
6. Boltze J, Förschler A, Nitzsche B, Waldmin D, Hoffmann A, Boltze CM, et al. Permanent middle cerebral artery occlusion in sheep: a novel large animal model of focal cerebral ischemia. J Cereb Blood Flow Metab. 2008;28(12):1951–64.
7. Tajiri N, Dailey T, Metcalf C, Mosley YI, Lau T, Staples M, et al. In vivo animal stroke models: a rationale for rodent and non-human primate models. Transl Stroke Res. 2013;4(3):308–1.
8. Boltze J, Wagner DC, Barthel H, Gounis MJ. Academic-industry collaboration in translational stroke research. Trans Stroke Res. 2016. doi:10.1007/s12975-016-0475-5
9. Begley CG, Buchan AM. Dirnagl U3. Robust research: institutions must do their part for reproducibility. Nature. 2015;525(7567):25–7.